QSAM Biosciences Other Liabilities

QSAM Biosciences (QSAM) currently reports a other liabilities of $0 as of December 2023. That compares with $-1.2M in the prior-year period — up 100.0% year over year. Use the charts on this page to explore QSAM Biosciences's other liabilities history and peer comparisons.

QSAM Biosciences's other liabilities increased from $-1.2M to $0 — a 100.0% year-over-year increase (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

QSAM Biosciences reported $0 in other liabilities as of December 2023. That compares with $-1.2M in the prior-year period — up 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for QSAM Biosciences, and consider following QSAM for alerts when major investors trade the stock.

QSAM Biosciences is classified in the Materials sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing QSAM with unrelated industries.